• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 207/34 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 207/34

Total number of patents in this class: 559

10-year publication summary

29
26
30
37
46
30
34
21
22
24
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Sunshine Lake Pharma Co., Ltd.
626
18
Takeda Pharmaceutical Company Limited
2712
17
Daiichi Sankyo Company, Limited
1890
16
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
775
12
Viatris Specialty LLC
161
11
Syngenta Crop Protection AG
6701
9
Eonhf, Inc.
45
7
FUJIFILM Corporation
30514
6
Activesite Pharmaceuticals, Inc.
17
6
Emory University
1719
6
Global Blood Therapeutics, Inc.
169
6
New York Blood Center, Inc.
169
6
Tetraphase Pharmaceuticals, Inc.
52
6
Accent Therapeutics, Inc.
26
6
Aligos Therapeutics, Inc.
163
6
Novartis AG
10262
5
AstraZeneca AB
2814
5
Bayer Cropscience AG
1844
5
Astellas Pharma Inc.
1044
5
Ono Pharmaceutical Co., Ltd.
421
5
Other owners 396